|
Dale Richardson serves as Vice President, Business Development. From 1996 to 2000, he was with Fresenius AG, one of the world leaders in kidney dialysis and pheresis, spending his last two years there as president/COO of Fresenius Hemotechnology, Inc. Fresenius Hemotechnology focused on a novel technology for rheumatoid arthritis, apheresis, autotransfusion, and blood-banking products. For the two years prior to Fresenius, he was senior vice president, marketing and sales, for McKesson Health Systems, managing two divisions of the world's largest drug distribution company. In 1981, Mr. Richardson began his medical career with Davol, a subsidiary of C.R.Bard, Inc., working up from sales representative to vice president of sales over an eight-year period. He then managed International Marketing, followed by worldwide sales and marketing responsibility, and finally was promoted to vice president of blood management products, where he had full P&L responsibility for a $20 million/year business unit.
Mr. Richardson earned his bachelor's degree in business administration from California State University, Hayward, and an MBA from West Coast University in Los Angeles. | 